Center Partnerships Diabetes Research Centers now highlights DRC Partner Institutions. Center partnerships are listed with location details and links to the partnership website. An overview of the partner institution and its research centers, institutions, and programs can also be viewed.

DIABETES RESEARCH CENTERS

Michael McManus PhD UCSF UCSF
The McManus lab studies fundamental processes relating to mammalian gene expression. We take high-throughput approaches, analyzing hundreds of thousands to millions of experiments at once, using complex libraries coupled to deep sequencing. The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
David P Olson David P Olson MD PhD University of Michigan University of Michigan
Using novel mouse models, Dr. Olson is exploring gene expression changes in specific neuronal populations in the brain that are known to be important in regulating energy balance; these studies are directed at examining the link between gene expression in specific areas of the brain and altered metabolism. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Alan R Saltiel Alan R Saltiel PhD UCSD-UCLA UCSD-UCLA
Dr. Alan Saltiel investigates the hormone insulin and its role in regulating cellular sugar levels, including how cells send and receive signals. Understanding these processes may shed light on dysfunctioning glucose and lipid metabolism, particularly as it related to Type 2 diabetes. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Julian P Whitelegge Julian P Whitelegge PhD UCSD-UCLA UCSD-UCLA
Julian Whitelegge received his Ph.D. from Imperial College of Science and Technology, University of London in 1989 and became heavily involved in mass spectrometry research in the mid nineties. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Carlos Bernal-Mizrachi MD Carlos Bernal-Mizrachi MD Washington University in St Louis Washington University in St Louis

Research

TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
Barbara Gower Barbara Gower PhD University of Alabama at Birmingham University of Alabama at Birmingham
Dr. Gower research interests are related to obesity and energy metabolism, with an emphasis on insulin secretion/action and the role of the endocrine system The Diabetes Research and Training Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.
Ji Lei MD MBA Boston Area Boston Area
Dr. Ji Lei is the director of the special service GMP facility for human islet/cell isolation and transplantation at Massachusetts General Hospital. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Matthias Hebrok Matthias Hebrok PhD UCSF UCSF
The main focus of our lab is to study the mechanisms that underlie mammalian pancreas organogenesis and pancreatic diseases, including diabetes and pancreatic cancer. The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
Christopher K Glass Christopher K Glass MD PhD UCSD-UCLA UCSD-UCLA
Christopher K. Glass is Professor of Cellular and Molecular Medicine and Professor of Medicine at the University of California, San Diego School of Medicine. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Kenneth W Dunn Kenneth W Dunn PhD Indiana University Indiana University
Dr. Dunn’s research addresses the development of advanced methods of quantitative optical microscopy, particularly intravital multiphoton microscopy. The Center for Diabetes and Metabolic Diseases (CDMD) at IU School of Medicine is a world-renowned center focused on centralizing and fostering research along five fundamental themes to strengthen the diabetes research base throughout Indiana.
Roland W Stein Roland W Stein PhD Vanderbilt University Vanderbilt University
Until recently, little detailed information was known about the factors controlling pancreas development and islet beta cell function. However, our understanding has increased greatly with the identification and molecular characterization of the islet-enriched MafA, MafB, and PDX-1 transcription factors. The Vanderbilt Diabetes Research and Training Center (DRTC), is a NIH-sponsored Diabetes Center that facilitates the discovery, application, and translation of scientific knowledge to improve the lives of people with diabetes.
Timothy R Nagy PhD University of Alabama at Birmingham University of Alabama at Birmingham
Dr. Nagy is a Professor of Nutrition Sciences, Director of the Division of Physiology and Metabolism, and Director of the PhD Program in Nutrition Sciences. The Diabetes Research and Training Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.
Seung K Kim Seung K Kim MD PhD Stanford University Stanford University
Seung K. Kim is Professor in the Department of Developmental Biology and, by courtesy, in the Department of Medicine (Oncology Division) at Stanford University School of Medicine, where he has been a faculty member since 1998. The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Graeme Bell Graeme Bell PhD University of Chicago University of Chicago
Dr. Bell’s research focuses on the genetics of diabetes mellitus. Ongoing studies in his laboratory include the genetics of type 2 diabetes in the Mexican American population of Starr County, Texas. The University of Chicago Diabetes Research and Training Center (DRTC) provides resources for the support and coordination of the research and training activities in diabetes and related metabolic and endocrine disorders of a large and growing number of independently funded but highly interactive investigators.
Bradford Lowell MD PhD Boston Area Boston Area
The Lowell Lab utilizes genetic engineering techniques in mice, in conjunction with electrophysiology, optogenetics, pharmacogenetics and rabies mapping, to elucidate central neurocircuits controlling feeding behavior, body weight homeostasis, and fuel metabolism. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Raimund I Herzog Raimund I Herzog MD MHS Yale University Yale University
Dr. Herzog’s laboratory is focused on characterizing and preventing its central nervous complications. He uses state-of-the-art technologies to define the impact of diabetes and intensive insulin treatment on brain metabolism and cognition. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.

Diabetes Centers Overview

Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.

In the Spotlight

Pilot & Feasibility Study
Center Publication
UCSF UCSF Albert Einstein College of Medicine Einstein 
Repression of Adipose Tissue Fibrosis through a PRDM16-GTF2IRD1 Complex Improves Systemic Glucose Homeostasis., Hasegawa, Yutaka, Ikeda Kenji, Chen Yong, Alba Diana L., Stifler Daniel, Shinoda Kosaku, Hosono Takashi, Maretich Pema, Yang Yangyu, Ishigaki Yasushi, et al. , Cell Metab, 2018 01 09, Volume 27, Issue 1, p.180-194.e6, (2018)
NIDDK Center
The Cystic Fibrosis Research and Translation Centers are part of an integrated program of research support designed to enhance multidisciplinary research in pathogenesis and treatment of cystic fibrosis.
Diabetes Resource
The Acute Renal Failure Trial Network (ATN) Study is a clinical research study that is jointly sponsored by the Department of Veterans Affairs and the National Institutes of Health in order to determine if an increased dose of dialysis will decrease mortality rates in patients with acute renal failure (ARF).